BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  Voyager and AbbVie Forge Another Neurodegenerative Therapy Collaboration Worth More Than $1 Billion

  Voyager Therapeutics struck a deal with Illinois-based AbbVie to develop and commercialize vectorized antibodies directed at pathological species of alpha-synuclein for the potential treatment of Parkinson’s disease.

  February 22, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Orchard Eyes 2020 for Filing BLA for ADA-SCID Gene Therapy

  Two-year follow-up data shows 100 percent overall survival and 100 percent event free survival in comparison to a historical standard of care from a historical control group.

  February 22, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Connecticut Aims to Grow Its Biotech Industry

  The state of Connecticut is embracing a new strategic vision for its biotech sector that could foment an addition of more than 6,000 new jobs over the next 10 years as the state looks to compete with neighboring New York and Massachusetts, both of which have a vibrant biotech and life science industry.

  February 22, 2019

   · 

  2 min read

   · 

  Alex Keown